Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024)

Historic Exchange Rate Effect for Seres Therapeutics (MCRB) over the last 4 years, with Q4 2024 value amounting to -$1000.0.

  • Seres Therapeutics' Exchange Rate Effect changed N/A to -$1000.0 in Q4 2024 from the same period last year, while for Sep 2024 it was $2000.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of -$1000.0 for FY2024, which is 15000.0% down from last year.
  • Per Seres Therapeutics' latest filing, its Exchange Rate Effect stood at -$1000.0 for Q4 2024.
  • In the past 5 years, Seres Therapeutics' Exchange Rate Effect registered a high of $1000.0 during Q4 2022, and its lowest value of -$2000.0 during Q3 2022.
  • For the 4-year period, Seres Therapeutics' Exchange Rate Effect averaged around -$400.0, with its median value being -$1000.0 (2021).
  • As far as peak fluctuations go, Seres Therapeutics' Exchange Rate Effect soared by 20000.0% in 2022, and later soared by 15000.0% in 2023.
  • Over the past 4 years, Seres Therapeutics' Exchange Rate Effect (Quarter) stood at -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024.
  • Its last three reported values are -$1000.0 in Q4 2024, $1000.0 for Q3 2023, and $1000.0 during Q4 2022.